OR34 Adrenal Tumors and Paragangliomas

Program: Abstracts - Orals, Poster Previews, and Posters
Oral Session
Adrenal HPA Axis-Clinical
Monday, April 4, 2016: 10:00 AM-11:30 AM
Room 253 (BCEC)
Chairs:
To Be Determined and Matthias Max Weber, Universitätsmedizin Johannes Gutenberg Universität Mainz, Mainz, Germany

Nothing to Disclose: MMW Disclosure Not Provided: HH, FB
10:00 AM
Carolyn Horton, MS, CGC, Michelle Jackson, MS, CGC, Amal Yussuf, Rachel McFarland, Holly LaDuca, MS, CGC and Kory Jasperson, MS, CGC, Ambry Genetics, Aliso Viejo, CA
10:15 AM
Ingo Janssen, MD1, Clara C Chen, MD2, Corina M Millo, MD3, Peter Herscovitch, MD3, Alexander Ling, MD4, Nicholas J. Patronas, MD5, David Taieb, MD6, Tito Fojo, MD, PhD7, Electron Kebebew, M.D.8 and Karel Pacak, MD, PhD, DSc9, (1)Eunice Kennedy Shriver, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD
(2)Nuclear Medicine Division, Radiology & Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD
(3)Positron Emission Tomography Department, NIH -Clinical Center, Bethesda, MD
(4)NIH/CC/DRD, NIH, Bethesda, MD
(5)Section of Neuroradiology, Radiology and Imaging Sciences, NIH, Bethesda, MD
(6)Department of Biophysics and Nuclear Medicine, La Timone University Hospital, Marseille Cedex 05, France
(7)Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
(8)Endocrine Oncology Branch, National Cancer Institute, NIH, Bethesda, MD
(9)PRAE, NICHD, NIH
10:30 AM
Yoshikiyo Ono, MD, PhD1, Ryo Morimoto, MD, PhD1, Yuta Tezuka, MD1, Kei Omata, MD1, Masahiro Nezu, MD1, Yasuhiro Igarashi, MD, PhD1, Yoshitsugu Iwakura, MD, PhD1, Masataka Kudo, MD, PhD1, Kazumasa Seiji, MD, PhD2, Kei Takase, MD, PhD2, Yuto Yamazaki, MD3, Yasuhiro Nakamura, MD, PhD3, Hironobu Sasano, MD, PhD4, Sadayoshi Ito, MD, PhD5 and Fumitoshi Satoh, MD, PhD1, (1)Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, Japan
(2)Department of Diagnostic Radiology, Tohoku University Hospital, Sendai, Japan
(3)Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan
(4)Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan
(5)Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Sendai, Japan
10:45 AM
Irina Bancos, MD1, Jolaine Hines2, Wiebke Arlt, MD, DSc, FRCP, FMedSci3, William F Young Jr., MD, MSc1 and Ravinder J. Singh, PhD4, (1)Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN
(2)Laboratory Medicine and Pathology, Mayo Clinic
(3)IMSR Inst of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom
(4)Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
11:00 AM
Miguel Debono, MD, MRCP, PhD1, Robert F Harrison, BSc PhD Ceng FIET2, Rita Chadarevian3, Carole Gueroult3, Jean-Louis Abitbol3 and John Newell-Price, MD, PhD, FRCP4, (1)Human Metabolism, Academic Unit of Endocrinology, University of Sheffield, Sheffield, United Kingdom
(2)University of Sheffield
(3)HRA Pharma, Paris, France
(4)The Medical School, University of Sheffield, Sheffield, United Kingdom
11:15 AM
Diana M Lopez, BA1, Miguel Angel Luque Fernandez, MPH2, Gail K Adler3, Alexander Turchin, MD, MS4 and Anand Vaidya, MD3, (1)Harvard Medical School, Boston, MA
(2)Harvard School of Public Health
(3)Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital/Harvard Medical School, Boston, MA
(4)Brigham and Women's Hospital, Harvard Medical School, Boston, MA

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire